← Eichor
Study identifier: NCT06988774 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Tubal Occlusion During Minimally Invasive Myomectomy

Condition: Fallopian Tube Patency Tests · Fibroid/Myoma (Uterus/Cervix) · Myomectomy  ·  Sponsor: Medstar Health Research Institute

PhaseNA
Planned participants50
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study uses a procedure called chromopertubation to look at how fibroids and fibroid surgery affect the fallopian tubes. Specifically, this study will test if the fallopian tubes are occluded or patent (open) before and after surgically removing fibroids. Chromopertubation is a commonly performed and well-established procedure that is done during laparoscopic surgery to determine if the fallopian tubes are open or blocked. It includes inserting a dilute solution of saline with a small amount of medical-grade blue dye (called methylene blue) into the uterine cavity to see if it spills out of the fallopian tubes. Chromopertubation is considered a safe procedure - the main risk is an allergic reaction to the dye, which is very rare. The minimum amount of methylene blue dye will be used to further reduce risks of a reaction. Open fallopian tubes are necessary to become pregnant without the use of IVF. While it is known that some conditions can affect the functioning of the fallopian tubes, there is a lack of research about how fibroids affect the tubes. It is also not known how much about how the process of removing fibroids may affect the fallopian tubes. The investigators hypothesize that tubal occlusion will be observed in patients with fibroids and that the frequency of tubal occlusion will change after myomectomy compared to pre-myomectomy. This study will be conducted entirely during planned surgery for laparoscopic myomectomy. Chromopertubation will be performed at …

This description comes directly from the study's public registry record.

Talk to the study team

Alexandra Snyder, MD  ·  202-877-6526  ·  alexandra.snyder@medstar.net

Mireille Truong, MD  ·  202-877-6526  ·  mireille.d.truong@medstar.net

Always discuss trial participation with your own doctor first.

Locations (1)

MedStar Washington Hospital CenterWashington D.C., District of Columbia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06988774